The genomically-adjusted radiation dose (GARD) can predict risk of local tumor recurrence and optimize radiation dose

Technique allows researchers to perform high-throughput measurements of multiple modalities of information from single cells

Study finds 21-gene assay was associated with savings of approximately $3,600 per patient in chemotherapy costs alone for people with high-risk breast cancer

In prenatal testing, genomics sometimes sees what genetic tests can’t

Ongoing trials are using both genomics and functional approaches to match tumor profiles to tailored therapies